In Vitro is proud to bring together two leading brands in the life science industry committed to partnering with dedicated scientists working towards preventing and containing this devastating outbreak.
Bio-Techne provides corresponding products and solutions for SARS-CoV-2 detection, cytokine monitoring and drug discovery to help the scientific researchers conquer the virus, and in addition, ATCC have made it a priority to support assay development needs with a variety of essential coronavirus research resources.
ACDbio has introduced new RNAscope probe to the COVID-19 coronavirus (V-NCOV2019-S, catalogue number 848561). Additionally, our team can design a new probe against any viral RNA for SARS-CoV-2.
We understand everyone’s research is unique. If you cannot find the molecular construct or nucleic acids required for your research, or you need a customised RNAscope probes or you want to use an existing antibody for an untested application, please contact our team at lifescience@invitro.com.au
Dr. Jesús F Bermejo-Martín is the Principal Investigator, Group For Biomedical Research in Respiratory Infection and Sepsis (BioSepsis) at the Institute of Biomedical Research of Salamanca (IBSAL) / Hospital Universitario Río Hortega de Valladolid. In this webinar, he will discuss how he profiles the host response to COVID-19 using the automated ELISA platform, Ella, while assessing severe COVID-19 characterized by a dysregulated host response to this virus.
In this webinar, you will learn about:
• The correlations between viral RNA load in plasma and biological responses to SARS-CoV-2 infection.
• The benefits and ease of using Ella for profiling your samples.